Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

NCT05717699 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT05717699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05717699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Lead sponsor
Capital Medical University
Phase
Phase 1
Overall status
Recruiting
Start date
January 4, 2023
Completion date
January 4, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, diffuse intrinsic pontine glioma, oncolytic virus